These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 4651413

  • 41. [Plasma acetate and bicarbonate kinetics and intolerance to acetate during and after renal dialysis].
    Bruno R, Grandvuillemin M, Olmer M, Cano JP.
    Pathol Biol (Paris); 1984 Sep; 32(7):768-71. PubMed ID: 6493812
    [Abstract] [Full Text] [Related]

  • 42. [The patient with chronic renal failure].
    Schammann T, Schindler R.
    Med Monatsschr Pharm; 2008 Nov; 31(11):417-26; quiz 427-8. PubMed ID: 19055161
    [Abstract] [Full Text] [Related]

  • 43. Doxycycline--a new formulation.
    Med Lett Drugs Ther; 1973 Jan 19; 15(2):5-6. PubMed ID: 4696895
    [No Abstract] [Full Text] [Related]

  • 44. Pharmacokinetics of deflazacort in renal transplanted and hemodialyzed children.
    Ferraris J, Krmar R, Flores D, Giogieri S, Díaz L, Tessler J.
    Clin Nephrol; 1998 Sep 19; 50(3):172-7. PubMed ID: 9776421
    [Abstract] [Full Text] [Related]

  • 45. [Long-term treatment with dialysis in chronic kidney failure using the artificial kidney Aue I].
    Lincke HU, Schröcke G.
    Z Gesamte Inn Med; 1968 Oct 01; 23(19):592-5 passim. PubMed ID: 5702922
    [No Abstract] [Full Text] [Related]

  • 46. Elimination of digoxin during maintenance haemodialysis.
    Iisalo E, Forsström J.
    Ann Clin Res; 1974 Aug 01; 6(4):203-6. PubMed ID: 4429332
    [No Abstract] [Full Text] [Related]

  • 47. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 01; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 48. Increased plasma guanylin levels in patients with impaired renal function.
    Kinoshita H, Nakazato M, Yamaguchi H, Matsukura S, Fujimoto S, Eto T.
    Clin Nephrol; 1997 Jan 01; 47(1):28-32. PubMed ID: 9021238
    [Abstract] [Full Text] [Related]

  • 49. Lymecycline or doxycycline for treatment of urinary-tract infections: a comparison of attained urine concentrations.
    Ericsson S, Gnarpe H.
    Microbios; 1978 Jan 01; 20(80):95-8. PubMed ID: 732594
    [Abstract] [Full Text] [Related]

  • 50. Observations on methods of assaying, and the value of monitoring plasma quinidine concentrations.
    Abramson FP, Yago KB, Feuillan P.
    Res Commun Chem Pathol Pharmacol; 1979 Mar 01; 23(3):631-4. PubMed ID: 461980
    [No Abstract] [Full Text] [Related]

  • 51. Changes in blood thiamphenicol levels in renal failure.
    Traeger J, Moskovchenko J, Monier JC, Zech P.
    Postgrad Med J; 1974 Oct 01; 50 Suppl 5():39-40. PubMed ID: 4470816
    [No Abstract] [Full Text] [Related]

  • 52. The serum half-life and urine concentrations of cephazolin sodium in patients with terminal renal failure: effect of haemodialysis.
    Eastwood JB, Gower PE, Curtis JR.
    Scott Med J; 1976 Sep 01; 20(5):240-3. PubMed ID: 1265473
    [Abstract] [Full Text] [Related]

  • 53. Effect of long-term alcohol consumption on the half-life of tetracycline and doxycycline in man.
    Neuvonen PJ, Penttilä O, Roos M, Tirkkonen J.
    Int J Clin Pharmacol Biopharm; 1976 Dec 01; 14(4):303-7. PubMed ID: 1002368
    [Abstract] [Full Text] [Related]

  • 54. Pharmacodynamics of practolol in chronic renal failure.
    Eastwood JB, Curtis JR, Smith RB.
    Br Med J; 1973 Nov 10; 4(5888):320-2. PubMed ID: 4758423
    [Abstract] [Full Text] [Related]

  • 55. [L-ascorbic acid and long-term dialysis program].
    Mydlík M, Derzsiová K, Takác M.
    Cas Lek Cesk; 1976 Jan 30; 115(4):115-9. PubMed ID: 1253213
    [No Abstract] [Full Text] [Related]

  • 56. [Common errors in pharmacotherapy of patients with chronic kidney disease].
    Maus S, Keller F.
    MMW Fortschr Med; 2011 Apr 21; 153(16):39-42. PubMed ID: 22329322
    [No Abstract] [Full Text] [Related]

  • 57. [Plasma catecholamines in kidney insufficiency].
    Ratge D, Wisser H.
    Dtsch Med Wochenschr; 1987 Oct 09; 112(41):1594. PubMed ID: 3665742
    [No Abstract] [Full Text] [Related]

  • 58. [Pharmacokinetic behavior of clofibrate in patients with kidney insufficiency].
    Hartlapp J, Kürten J, Klehr U, Gugler R.
    Verh Dtsch Ges Inn Med; 1987 Oct 09; 83():1709-11. PubMed ID: 611915
    [No Abstract] [Full Text] [Related]

  • 59. Administration of ticarcillin to patients with severe renal failure.
    Davies M, Morgan JR, Anand C.
    Chemotherapy; 1974 Oct 09; 20(6):339-41. PubMed ID: 4442291
    [No Abstract] [Full Text] [Related]

  • 60. Infections in renal failure.
    Hatchuel W.
    S Afr Med J; 1973 May 12; 47(18):760. PubMed ID: 4710165
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.